ZA201607068B - Methods for treating hypersomnia - Google Patents

Methods for treating hypersomnia

Info

Publication number
ZA201607068B
ZA201607068B ZA2016/07068A ZA201607068A ZA201607068B ZA 201607068 B ZA201607068 B ZA 201607068B ZA 2016/07068 A ZA2016/07068 A ZA 2016/07068A ZA 201607068 A ZA201607068 A ZA 201607068A ZA 201607068 B ZA201607068 B ZA 201607068B
Authority
ZA
South Africa
Prior art keywords
methods
treating hypersomnia
hypersomnia
treating
Prior art date
Application number
ZA2016/07068A
Other languages
English (en)
Inventor
Lien Lyndon
Original Assignee
Balance Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Balance Therapeutics Inc filed Critical Balance Therapeutics Inc
Publication of ZA201607068B publication Critical patent/ZA201607068B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2016/07068A 2014-04-15 2016-10-13 Methods for treating hypersomnia ZA201607068B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461979918P 2014-04-15 2014-04-15
PCT/US2015/025696 WO2015160766A1 (en) 2014-04-15 2015-04-14 Methods for treating hypersomnia

Publications (1)

Publication Number Publication Date
ZA201607068B true ZA201607068B (en) 2023-01-25

Family

ID=54324484

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2016/07068A ZA201607068B (en) 2014-04-15 2016-10-13 Methods for treating hypersomnia

Country Status (12)

Country Link
US (3) US10688103B2 (enExample)
EP (1) EP3131904A4 (enExample)
JP (2) JP6672264B2 (enExample)
KR (1) KR20170005415A (enExample)
CN (1) CN106459066B (enExample)
AU (2) AU2015247829B2 (enExample)
CA (1) CA2945705A1 (enExample)
EA (1) EA201692061A1 (enExample)
IL (1) IL248255A0 (enExample)
MX (1) MX2016013340A (enExample)
WO (1) WO2015160766A1 (enExample)
ZA (1) ZA201607068B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10278977B2 (en) 2016-06-06 2019-05-07 Umecrine Cognition Ab Methods for treating hypersomnolence
US11529358B2 (en) 2017-05-10 2022-12-20 Emory University Treatment of conditions associated with myotonic dystrophy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006137746A (ja) 2004-10-13 2006-06-01 Otsuka Pharmaceut Factory Inc オレキシン誘導組成物
ES2573733T3 (es) 2006-05-22 2016-06-09 The Board Of Trustees Of The Leland Stanford Junior University Tratamiento farmacológico del deterioro cognitivo
US20110038850A1 (en) 2007-01-05 2011-02-17 Didier Bagnol G Protein-Coupled Receptor and Modulators Thereof For The Treatment of Gaba-Related Neurological Disorders Including Sleep-Related Disorders
EP2300015A4 (en) * 2008-03-12 2011-06-29 Univ Emory USE OF GABAA RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXCESSIVE SLIP AND DISEASES RELATED TO EXCESSIVE SLIP
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
US8946206B2 (en) * 2010-12-17 2015-02-03 The Board Of Trustees Of The Leland Stanford Junior University Methods for improving cognitive function
JP2014511382A (ja) 2011-02-23 2014-05-15 コエルルウス リミテッド フルマゼニル錯体、それを含む組成物、およびその使用
DK2705013T3 (en) 2011-05-04 2016-07-18 Balance Therapeutics Inc Pentylenetetrazolderivater

Also Published As

Publication number Publication date
US20230115839A1 (en) 2023-04-13
JP2020105200A (ja) 2020-07-09
WO2015160766A1 (en) 2015-10-22
JP6672264B2 (ja) 2020-03-25
US20180169107A1 (en) 2018-06-21
US20200360398A1 (en) 2020-11-19
EP3131904A4 (en) 2017-11-22
KR20170005415A (ko) 2017-01-13
JP2017511386A (ja) 2017-04-20
US10688103B2 (en) 2020-06-23
AU2015247829B2 (en) 2019-12-05
CA2945705A1 (en) 2015-10-22
EP3131904A1 (en) 2017-02-22
IL248255A0 (en) 2016-11-30
CN106459066A (zh) 2017-02-22
AU2019268190A1 (en) 2019-12-12
CN106459066B (zh) 2020-07-07
AU2015247829A1 (en) 2016-10-27
EA201692061A1 (ru) 2017-03-31
MX2016013340A (es) 2017-02-09

Similar Documents

Publication Publication Date Title
IL323396A (en) Cancer treatment methods
IL289947A (en) A method for treating cancer
IL249600A0 (en) Bone marrow cell transplant treatment
PL3110988T3 (pl) Sposoby obróbki materiałów zawierających lit
IL252716A0 (en) Anti-csf1r antibodies for the treatment of pvns
IL254393A0 (en) Methods for treating diseases associated with pathological changes in protein
SG11201609350XA (en) Methods for inhibiting necroptosis
GB201401430D0 (en) Treatment process
GB201404468D0 (en) Process
IL249936A0 (en) Methods for treating hypotension
IL249475A0 (en) Methods for treating itching
IL246558A0 (en) New methods of cancer treatment
GB201402950D0 (en) Process
GB201402782D0 (en) Process
GB201400137D0 (en) Process
SG11201609522TA (en) Methods for treating cardiovascular diseases
GB201414192D0 (en) Apparatus for treating animals
PT3250218T (pt) Péptido natkide para o tratamento da obesidade
PT3172297T (pt) Método para tratar algas
GB201403057D0 (en) Process
ZA201607068B (en) Methods for treating hypersomnia
GB2534681B (en) Treatment apparatus
SG11201706885RA (en) Novel treatment method
PL3113919T3 (pl) Sposób powlekania fragmentu powierzchni
GB201400311D0 (en) Treating Susceptibility